SUBSCRIBE
SUBSCRIBE

MAIA Biotechnology

IN THE PRESS
BioMidwest
MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders
March 5, 2024
 · 
4 min read
Business
MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor
February 27, 2024
 · 
6 min read
Drug Development
MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer
February 22, 2024
 · 
6 min read
Drug Development
MAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancer
February 7, 2024
 · 
7 min read
BioMidwest
MAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting Compounds
January 24, 2024
 · 
5 min read
Drug Development
MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024
January 17, 2024
 · 
7 min read
BioMidwest
MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024
January 5, 2024
 · 
4 min read
Drug Development
MAIA Biotechnology Announces Dose Selection in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer
December 19, 2023
 · 
6 min read
Deals
MAIA Biotechnology Announces Closing of $4 Million Registered Direct Offering
November 17, 2023
 · 
5 min read
BioMidwest
MAIA Biotechnology Announces $4 Million Registered Direct Offering
November 15, 2023
 · 
6 min read
Load More
JOBS